Gentle Laxative
- Product NDC
- 21130-410
- 11-digit product format
- 211300410
- Labeler code
- 21130
- Product ID
- 21130-410_3eaa649e-0aa5-c65f-e063-6294a90a314e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bisacodyl
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- BETTER LIVING BRANDS LLC.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2023-06-01
- Substance
- BISACODYL
- Active strength
- 5 mg/1
- Pharmacologic classes
- Increased Large Intestinal Motility [PE], Stimulant Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 21130-410-20 | 302b2466d912… | e7b80fea0513… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 21130-410-52 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 21130-410-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 21130-410-52 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 21130-410-20 | 0efc9e666f02… | f202fb6c5f17… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 21130-410-52 | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Gentle Laxative
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| BISACODYL | 5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 10X0709Y6I | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 308753 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| f29d57f6-0938-d459-e053-2995a90ad86b | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| e2db08c6-133f-4f4f-afb4-e90a2418d6f6 | Product name | 1 | 20230320 |
| 11ed6f83-cdd2-4637-8379-b1a1d3ae3cde | Product name | 1 | 20181101 |
| 86c45a79-b9f0-4476-a27c-6e10db098497 | Product name | 1 | 20180125 |
| 89dac932-b90a-4410-9ab1-84c53e57de25 | Product name | 1 | 20150316 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 21130-410-20 | 2025-02-11 | 14R_Albertsons_21130-410_Bisacodyl Delayed Release Tablets 5 mg |
| 21130-410-52 | 2025-02-11 | 14R_Albertsons_21130-410_Bisacodyl Delayed Release Tablets 5 mg |
| 21130-410-20 | 2025-01-30 | 14R_Albertsons_21130-410_Bisacodyl Delayed Release Tablets 5 mg |
| 21130-410-52 | 2025-01-30 | 14R_Albertsons_21130-410_Bisacodyl Delayed Release Tablets 5 mg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 21130-410-20 | Gentle Laxative | 200 in 1 BOTTLE | TABLET, DELAYED RELEASE | 200 | 4 | |
| 21130-410-52 | Gentle Laxative | 25 in 1 BLISTER PACK | TABLET, DELAYED RELEASE | 25 | 4 | |
| 21130-410-52 | Gentle Laxative | 1 in 1 CARTON | TABLET, DELAYED RELEASE | 1 | 4 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Epsom Salt | MAGNESIUM SULFATE | Target Corporation | f7309f4a-f1f5-420e-bfc7-fb4495a5afba | 2024-10-24 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Target Corporation | 2540ae39-2218-0f6a-e063-6294a90a5efc | 2024-10-24 | Warnings | M007 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | Sam's West Inc | b0e99ebb-41fc-459f-86d2-f0e3527f97b0 | 2024-10-24 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | A-S Medication Solutions | ef05ad45-7082-43e6-9533-a79c5aa0f373 | 2024-10-22 | Warnings | M007 |
| Bliss GVS Children | GLYCERIN | Bliss GVS Pharma Limited | 03237ed2-265f-4acd-b504-d82b9263287c | 2024-10-17 | Warnings | M007 |
| NATURAL Epsom Salt | MAGNESIUM SULFATE | Universal Distribution Center LLC | b2682e51-ffa4-4556-b2a6-b0dbd543fd4f | 2024-10-16 | Warnings | M007 |
| Bliss GVS | GLYCERIN | Bliss GVS Pharma Limited | 1a3982a1-9ce9-4a1a-ba73-ebe2d8647109 | 2024-10-10 | Warnings | M007 |
| Bisacodyl | BISACODYL | Padagis US LLC | 7eada0fc-5f83-43da-a56f-b0f537298208 | 2024-10-10 | Warnings | M007 |
| exchange select stool softener | DOCUSATE SODIUM | Army & Air Force Exchange Service | 14985848-d791-42b9-ad7e-810a85bb1ee1 | 2024-10-07 | Warnings | M007 |
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Proficient Rx LP | 8678a3ee-0e2c-4c95-ad2e-83aa601f3238 | 2024-10-01 | Warnings | M007 |
| Pedia-Lax | DOCUSATE SODIUM | C.B. Fleet Company, Inc. | 0e908bea-ebab-44e7-919c-90002e6f5d42 | 2024-10-01 | Warnings | M007 |
| Natural Vegetable Laxative and Stool Softener | DOCUSATE SODIUM AND SENNOSIDES | BETTER LIVING BRANDS LLC. | f2c562e1-4080-44cb-e053-2a95a90a4222 | 2024-09-25 | Warnings | M007 |
| SENNA-S LAXATIVE WITH STOOL SOFTENER | SENNOSIDES | Basic Drugs, Inc. | d32b9956-fc04-8d64-e053-2a95a90a17b3 | 2024-09-14 | Warnings | M007 |
| DOCUSATE SODIUM, EXTRA STRENGTH 250 MG | DOCUSATE SODIUM | Advanced Rx LLC | e8be12c5-c591-eadd-e053-2a95a90a431b | 2024-09-13 | Warnings | M007 |
| Senna | SENNOSIDES | Proficient Rx LP | 5f7f0df4-dabe-4c8f-a2b5-766f20af2f46 | 2024-09-01 | Warnings | M007 |
| Fiber caplets 147 | CALCIUM POLYCARBOPHIL | Chain Drug Marketing Association Inc. | 17e2a50d-1867-49fe-e063-6394a90a56df | 2024-08-27 | Warnings | M007 |
| MAXIMUM STRENGTH LAXATIVE PILLS | SENNOSIDES | TARGET CORPORATION | 7cae52ae-931c-3e7c-e053-2991aa0a8396 | 2024-08-22 | Warnings | M007 |
| STOOL SOFTENER AND STIMULANT LAXATIVE | DOCUSATE SODIUM AND SENNOSIDES | TARGET CORPORATION | 7cac99da-8d89-0aee-e053-2991aa0a0fd9 | 2024-08-22 | Warnings | M007 |
| SENNA LAXATIVE | SENNOSIDES 8.6 MG | TARGET CORPORATION | 7cab058f-3647-7124-e053-2a91aa0a41bd | 2024-08-22 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | Padagis Israel Pharmaceuticals Ltd | bce3b245-ec47-4e62-9cad-bb12d0812c18 | 2024-08-15 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 308753 | bisacodyl 5 MG Delayed Release Oral Tablet | PSN | f29d57f6-0938-d459-e053-2995a90ad86b | 4 |
| 308753 | bisacodyl 5 MG Delayed Release Oral Tablet | SCD | f29d57f6-0938-d459-e053-2995a90ad86b | 4 |
| 308753 | bisacodyl 5 MG Enteric Coated Oral Tablet | SY | f29d57f6-0938-d459-e053-2995a90ad86b | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 21130-410-20 | 21130041020 | 200 TABLET, DELAYED RELEASE in 1 BOTTLE (21130-410-20) | 2023-06-22 | No | No | Current | |
| 21130-410-52 | 21130041052 | 1 BLISTER PACK in 1 CARTON (21130-410-52) / 25 TABLET, DELAYED RELEASE in 1 BLISTER PACK | 1 blister pack | 2023-06-01 | No | No | Current |